Related Experiment Video
Updated: Dec 12, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Transient Cardiomyopathy in a Patient With Coronavirus Disease-2019
B K Anupama1, Simant S Thapa1, Ioana Amzuta1
1SUNY Upstate Medical University, Syracuse, NY, USA.
Insights
Severe COVID-19 can cause temporary heart muscle damage (cardiomyopathy) and shock. Treatment with convalescent plasma and inotropic support led to full recovery of heart function in one patient.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease-19 (COVID-19) has been associated with various cardiovascular complications.
- Systemic inflammation plays a significant role in the pathophysiology of severe COVID-19.
Observation:
- A 66-year-old male patient with severe COVID-19 presented with cardiogenic shock.
- Echocardiography revealed decreased left ventricular ejection fraction and global hypokinesia.
- The patient exhibited a robust systemic inflammatory response.
Findings:
- Convalescent plasma therapy and inotropic support were administered.
- Left ventricular function fully recovered following treatment.
- Cardiac function recovery correlated with a decrease in inflammatory markers.
Implications:
- This case demonstrates transient, reversible cardiomyopathy in severe COVID-19.
- Acute cardiac dysfunction in COVID-19 is associated with profound systemic inflammation.
- Understanding this association may guide therapeutic strategies for cardiac complications in COVID-19.
Abstract:
A 66-year-old male patient with coronavirus disease-19 (COVID-19) developed cardiogenic shock with echocardiographic evidence of decreased left ventricular ejection fraction and global hypokinesia concomitant with a robust systemic inflammatory response. Following the administration of convalescent plasma therapy and inotropic support, left ventricular function recovered fully in accordance with the decrease in the concentration of the inflammatory markers. Thus, we demonstrate the presence of transient reversible cardiomyopathy in a patient with severe COVID-19 and illustrate the association of acute cardiac dysfunction with profound systemic inflammation among COVID-19 patients.
More Related Videos
10:08Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis III: Medical Management
Cardiomyopathy VI: Nursing Management